Literature DB >> 14583569

Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus.

E M C Sella1, E I Sato, W A Leite, J A Oliveira Filho, A Barbieri.   

Abstract

OBJECTIVE: To evaluate the prevalence of myocardial perfusion abnormalities and the possible association between myocardial perfusion defects and traditional coronary artery disease (CAD) risk factors as well as systemic lupus erythematosus (SLE) related risk factors. PATIENTS AND METHODS: Female patients with SLE, disease duration >5 years, age 18-55 years, who had used steroids for at least one year were enrolled. Traditional CAD risk factors evaluated were arterial hypertension, diabetes mellitus, dyslipidaemia, postmenopausal status, smoking, obesity, and premature family CAD profile. Myocardial perfusion scintigraphy was evaluated by single photon emission computed tomography with technetium 99m-sestamibi at rest and after dipyridamole induced stress.
RESULTS: Eight two female patients with SLE without angina pectoris with mean (SD) age 37 (10) years, disease duration 127 (57) months, SLE Disease Activity Index (SLEDAI) score 6 (5), and SLICC/ACR-DI score 2 (2) were evaluated. Myocardial perfusion abnormalities were found in 23 patients (28%). The mean (SD) number of CAD risk factors was 2.2 (1.6). There was a significant positive correlation between age and number of CAD risk factors. Lower high density lipoprotein (HDL) cholesterol level showed a significant association with abnormal scintigraphy. Logistic regression analysis showed that lower HDL cholesterol level and diabetes mellitus were associated with myocardial perfusion abnormalities. Current vasculitis was also associated with abnormal scintigraphy.
CONCLUSIONS: Lower HDL cholesterol level and diabetes mellitus have a significant influence on abnormal myocardial perfusion results found in asymptomatic patients with SLE. Current vasculitis was associated with abnormal myocardial scintigraphy. These data suggest that abnormal myocardial scintigraphy may be related to subclinical atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14583569      PMCID: PMC1754361          DOI: 10.1136/ard.62.11.1066

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  50 in total

1.  Premature coronary artery disease in systemic lupus erythematosus in the absence of corticosteroid use.

Authors:  P Rahman; D D Gladman; M B Urowitz
Journal:  J Rheumatol       Date:  2000-05       Impact factor: 4.666

2.  Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

Authors:  J M Esdaile; M Abrahamowicz; T Grodzicky; Y Li; C Panaritis; R du Berger; R Côte; S A Grover; P R Fortin; A E Clarke; J L Senécal
Journal:  Arthritis Rheum       Date:  2001-10

Review 3.  Epidemiology of cardiovascular disease in systemic lupus erythematosus.

Authors:  C Aranow; E M Ginzler
Journal:  Lupus       Date:  2000       Impact factor: 2.911

Review 4.  Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort.

Authors:  M Petri
Journal:  Lupus       Date:  2000       Impact factor: 2.911

Review 5.  Vascular imaging: changing the face of cardiovascular research.

Authors:  S Manzi; L H Kuller; D Edmundowicz; K Sutton-Tyrrell
Journal:  Lupus       Date:  2000       Impact factor: 2.911

6.  Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus.

Authors:  P Rahman; M B Urowitz; D D Gladman; I N Bruce; J Genest
Journal:  J Rheumatol       Date:  1999-11       Impact factor: 4.666

7.  Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities.

Authors:  I N Bruce; R J Burns; D D Gladman; M B Urowitz
Journal:  J Rheumatol       Date:  2000-10       Impact factor: 4.666

Review 8.  Premature atherosclerosis in systemic lupus erythematosus.

Authors:  I N Bruce; D D Gladman; M B Urowitz
Journal:  Rheum Dis Clin North Am       Date:  2000-05       Impact factor: 2.670

9.  The role of technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography (SPECT) in the detection of cardiovascular involvement in systemic lupus erythematosus patients with non-specific chest complaints.

Authors:  S S Sun; Y C Shiau; S C Tsai; C C Lin; A Kao; C C Lee
Journal:  Rheumatology (Oxford)       Date:  2001-10       Impact factor: 7.580

10.  Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities.

Authors:  Ian N Bruce; Dafna D Gladman; Dominique Ibañez; Murray B Urowitz
Journal:  J Rheumatol       Date:  2003-02       Impact factor: 4.666

View more
  12 in total

1.  [Cardiovascular monitoring of patients with systemic lupus erythematosus].

Authors:  H Schotte; H Becker; W Domschke; M Gaubitz
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

2.  Cardiovascular Disease Prevention Counseling Program for Systemic Lupus Erythematosus Patients.

Authors:  Cécile M Yelnik; Monica Richey; Virginia Haiduc; Sotiria Everett; Meng Zhang; Doruk Erkan
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-06-26       Impact factor: 4.794

3.  Blood pressure in a hypertensive mouse model of SLE is not salt-sensitive.

Authors:  Keisa W Mathis; Marcia Venegas-Pont; Chester W Masterson; Katie L Wasson; Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-14       Impact factor: 3.619

4.  Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus.

Authors:  Keisa W Mathis; Marcia Venegas-Pont; C Warren Masterson; Nicholas J Stewart; Katie L Wasson; Michael J Ryan
Journal:  Hypertension       Date:  2012-01-30       Impact factor: 10.190

Review 5.  Endothelial function and endothelial progenitor cells in systemic lupus erythematosus.

Authors:  Anselm Mak; Jerry Kok Yen Chan
Journal:  Nat Rev Rheumatol       Date:  2022-04-07       Impact factor: 20.543

6.  High-sensitivity cardiac troponin I is a biomarker for increased arterial stiffness in systemic lupus erythematous women with normal kidney function.

Authors:  J M Sabio; Carlos Garcia-de Los Ríos; Marta Medina-Casado; María Del Mar Del Águila-García; Rafael Cáliz-Cáliz; Antonio Díaz-Chamorro
Journal:  Rheumatol Int       Date:  2022-09-12       Impact factor: 3.580

7.  Subclinical atherosclerosis in systemic lupus erythematosus patients and its relationship to disease activity and damage indices.

Authors:  S Fadda; H Nassar; S M Gamal; H Al-azizi
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

8.  Acute coronary syndrome as a first presentation of systemic lupus erythematosus in a teenager: revascularization by hybrid coronary artery bypass graft surgery and percutaneous coronary intervention: case report.

Authors:  P K Mehta; H Samady; T A Vassiliades; W M Book
Journal:  Pediatr Cardiol       Date:  2007-12-01       Impact factor: 1.655

9.  Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease.

Authors:  Allison B Reiss; Kamran Anwar; Joan T Merrill; Edwin S L Chan; Nahel W Awadallah; Bruce N Cronstein; H Michael Belmont; Elise Belilos; Gary Rosenblum; Kristina Belostocki; Lois Bonetti; Kowser Hasneen; Steven E Carsons
Journal:  Rheumatol Int       Date:  2009-06-23       Impact factor: 2.631

10.  Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors.

Authors:  Carlos Borelli Zeller; Simone Appenzeller
Journal:  Curr Cardiol Rev       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.